Americas Health Insurance Plans

National trade association for health insurers.

Based in DC

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $280K in lobbying spend across 6 quarterly filings, Americas Health Insurance Plans is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2019.

$280K
Total Spend
2
Years Active
1
Firms Hired
5
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$200K
2019$80K

Issues Lobbied

Taxation

Lobbying Firms

Harbinger Strategies, LLC

Lobbyists

John O'neillKyle NevinsSteve StombresManny RossmanJonathan Slemrod

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Taxation

  • •Health Insurance tax repeal; H.R.1, Tax Reform Act of 2017 (Public Law No. 115-97) - Issues related to tax reform.
  • •Health Insurance tax repeal; H.R.1, Tax Reform Act of 2017 (Public Law No. 115-97) - Issues related to tax reform.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Meta Platforms, INC. and Various Subsidiaries
$168.9M total spend
America's Health Insurance Plans INC (Ahip)
$96.4M total spend
Bayer Corporation (Consolidated Report)
$73.0M total spend
Toyota Motor North America INC (Tma)
$64.9M total spend
Dow Chemical Company DBA Dow
$60.4M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.